PMID- 36262975
OWN - NLM
STAT- MEDLINE
DCOM- 20221021
LR  - 20221021
IS  - 2314-6141 (Electronic)
IS  - 2314-6133 (Print)
VI  - 2022
DP  - 2022
TI  - Emerging Role of Dendritic Cell Intervention in the Treatment of Inflammatory 
      Bowel Disease.
PG  - 7025634
LID - 10.1155/2022/7025634 [doi]
LID - 7025634
AB  - Dendritic cells (DCs) are the most important antigen-presenting cells and are 
      pivotal in initiating effective adaptive immune responses to induce immune 
      tolerance and maintain immune homeostasis. Inflammatory bowel disease (IBD), 
      including Crohn's disease and ulcerative colitis, is chronic, intestinal 
      inflammatory and autoimmune disorder. DCs participate in IBD pathogenesis. This 
      review is aimed at briefly discussing the role of DCs in IBD and the relationship 
      between them and highlighting the prominent role of these cells in the treatment 
      of these disorders.
CI  - Copyright (c) 2022 Donglei Sun et al.
FAU - Sun, Donglei
AU  - Sun D
AUID- ORCID: 0000-0002-7930-7544
AD  - Department of Gastroenterology, The Second Hospital of Hebei Medical University, 
      Hebei Key Laboratory of Gastroenterology, Hebei Institute of Gastroenterology, 
      Shijiazhuang, China.
FAU - Li, Chenyang
AU  - Li C
AUID- ORCID: 0000-0002-7498-8408
AD  - Department of Gastroenterology, The Second Hospital of Hebei Medical University, 
      Hebei Key Laboratory of Gastroenterology, Hebei Institute of Gastroenterology, 
      Shijiazhuang, China.
FAU - Chen, Shuang
AU  - Chen S
AD  - Department of Pediatrics and Department of Biomedical Science, Cedars Sinai 
      Medical Center, Los Angeles, USA.
FAU - Zhang, Xiaolan
AU  - Zhang X
AUID- ORCID: 0000-0002-7047-3634
AD  - Department of Gastroenterology, The Second Hospital of Hebei Medical University, 
      Hebei Key Laboratory of Gastroenterology, Hebei Institute of Gastroenterology, 
      Shijiazhuang, China.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20221010
PL  - United States
TA  - Biomed Res Int
JT  - BioMed research international
JID - 101600173
SB  - IM
MH  - Humans
MH  - *Inflammatory Bowel Diseases/pathology
MH  - *Crohn Disease/pathology
MH  - *Colitis, Ulcerative/pathology
MH  - Dendritic Cells
PMC - PMC9576373
COIS- All authors declare no conflicts of interest in this paper.
EDAT- 2022/10/21 06:00
MHDA- 2022/10/22 06:00
PMCR- 2022/10/10
CRDT- 2022/10/20 02:50
PHST- 2022/07/21 00:00 [received]
PHST- 2022/09/27 00:00 [accepted]
PHST- 2022/10/20 02:50 [entrez]
PHST- 2022/10/21 06:00 [pubmed]
PHST- 2022/10/22 06:00 [medline]
PHST- 2022/10/10 00:00 [pmc-release]
AID - 10.1155/2022/7025634 [doi]
PST - epublish
SO  - Biomed Res Int. 2022 Oct 10;2022:7025634. doi: 10.1155/2022/7025634. eCollection 
      2022.